Morbidity and mortality associated with gastrectomy for gastric cancer

Annals of Surgical Oncology

Volumn 21, Issue 9, 2014, Pages 3008-3014

  Papenfuss, Wesley A ^a   Kukar, Moshim ^a   Oxenberg, Jacqueline ^a   Attwood, Kristopher ^a   Nurkin, Steven ^a   Malhotra, Usha ^a   Wilkinson, Neal W ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL LYMPHADENECTOMY; ABDOMINAL SURGERY; AGE; AGED; ARTICLE; CANCER SURGERY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLON RESECTION; DIABETES MELLITUS; DISEASE ASSOCIATION; ESOPHAGUS RESECTION; FACTUAL DATABASE; FEMALE; GASTRECTOMY; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INTESTINE RESECTION; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MORBIDITY; MULTICENTER STUDY (TOPIC); PANCREAS RESECTION; PARTIAL GASTRECTOMY; SPLENECTOMY; STOMACH CANCER; SURGICAL MORTALITY; SURGICAL RISK; TOTAL STOMACH RESECTION; CANCER STAGING; CLINICAL TRIAL; FOLLOW UP; MORTALITY; MULTICENTER STUDY; PATHOLOGY; POSTOPERATIVE COMPLICATION; PROGNOSIS; PROSPECTIVE STUDY; STOMACH NEOPLASMS; SURVIVAL RATE;

FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; MALE; MORBIDITY; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 84906238584     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-3664-z     Document Type: Article

References (29)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11-30.
2. Bertuccio P, Chatenoud L, Levi F, et al. Recent patterns in gastric cancer: a global overview. Int J Cancer. 2009;125(3):666-673.
3. Hundahl SA, Macdonald JS, Benedetti J, Fitzsimmons T. Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment. Ann Surg Oncol. 2002;9(3):278-286. (Pubitemid 34298633)
4. Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345(10):725-730.
5. Bonenkamp JJ, Hermans J, Sasako M, Van De Velde CJH. Extended lymph-node dissection for gastric cancer. N Engl J Med. 1999;340(12):908-914. (Pubitemid 29141051)
6. Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Br J Cancer. 1999;79(9-10):1522-1530. (Pubitemid 29116815)
7. Hundahl SA, Wanebo HJ. Changing gastric cancer treatment in the United States and the pursuit of quality. Eur J Surg Oncol. 2005;31(6):605-615. (Pubitemid 40975242)
8. Hartgritik HH, Van De Velde CJH, Putter H, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch Gastric Cancer Group trial. J Clin Oncol. 2004;22(11):2069-2077.
9. Ajani JA, Bentrem DJ, Besh S, et al. Gastric cancer, version 2.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2013;11(5):531-546.
10. Ajani JA, Mayer RJ, Ota DM, et al. Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma. J Natl Cancer Inst. 1993;85(22):1839-1844. (Pubitemid 23333617)
11. Leichman L, Silberman H, Leichman CG, et al. Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal therapy for gastric cancer: a University of Southern California pilot program. J Clin Oncol. 1992;10(12):1933-1942. (Pubitemid 23064206)
12. Wilkinson NW, Howe J, Gay G, Patel-Parekh L, Scott-Conner C, Donohue J. Differences in the pattern of presentation and treatment of proximal and distal gastric cancer: results of the 2001 gastric patient care evaluation. Ann Surg Oncol. 2008;15(6):1644-1650.
13. Accreditation Council for Graduate Medical Education. General surgery case logs. Updated 2012. http://www.acgme.org/acgmeweb/Portals/0/GSNatData1112. pdf.
14. La Torre M, Nigri G, Ferrari L, Cosenza G, Ravaioli M, Ramacciato G. Hospital volume, margin status, and long-term survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg. 2012;78(2):225-229.
15. Kneuertz PJ, Pitt HA, Bilimoria KY, et al. Risk of morbidity and mortality following hepato-pancreato-biliary surgery. J Gastrointest Surg. 2012;16(9):1727-1735.
16. Dhungel B, Diggs BS, Hunter JG, Sheppard BC, Vetto JT, Dolan JP. Patient and peri-operative predictors of morbidity and mortality after esophagectomy: American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP), 2005-2008. J Gastrointest Surg. 2010;14(10):1492-1501.
17. Ingraham AM, Richards KE, Hall BL, Ko CY, eds. Quality improvement in surgery: the American College of Surgeons National Surgical Quality Improvement Program approach. Adv Surg. 2010;44:251-267.
18. ACS NSQIP. ACS NSQIP - classic. Variables & definitions. Updated 2010. http://nsqip.healthsoftonline.com/lib/Documents/Ch-4-Variables- Definitions-062810.pdf. Accessed Nov 2013.
19. Sasako M. Gastric cancer eastern experience. Surg Oncol Clin North Am. 2012;21(1):71-77.
20. Songun I, Putter H, Kranenbarg EMK, Sasako M, van de Velde CJH. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide dutch D1D2 trial. Lancet Oncol. 2010;11(5):439-449.
21. Sano T, Kodera Y. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14(2):113-123.
22. Min JS, Jin SH, Park S, Kim SB, Bang HY, Lee JI. Prognosis of curatively resected pT4b gastric cancer with respect to invaded organ type. Ann Surg Oncol. 2012;19(2):494-501.
23. Hundahl SA. Surgery for gastric cancer: what the trials indicate. Surg Oncol Clin North Am. 2012;21(1):79-97.
24. Van der Geest LGM, Portielje JEA, Wouters MWJM, et al. Complicated postoperative recovery increases omission, delay and discontinuation of adjuvant chemotherapy in patients with stage III colon cancer. Colorectal Dis. 2013;15(10):E582-E591.
25. Merkow RP, Bentrem DJ, Mulcahy MF, et al. Effect of postoperative complications on adjuvant chemotherapy use for stage III colon cancer. Ann Surg. 2013;258(6):847-853.
26. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11-20.
27. Bouché O, Ychou M, Burtin P, et al. Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801). Ann Oncol. 2005;16(9):1488-1497. (Pubitemid 41226403)
28. Merkow RP, Kmiecik TE, Bentrem DJ, et al. Effect of including cancer-specific variables on models examining short-term outcomes. Cancer. 2013;119(7):1412-1419.
29. Ychou M, Boige V, Pignon JP, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol. 2011;29(13):1715-1721.